NorthCrest Asset Manangement’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
2025
Q4
$689K Buy
2025
Q3
$738K Buy
2025
Q2
Sell
2025
Q1
$323K Buy